These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3679279)

  • 1. Elevated plasma glutamate levels in colorectal carcinoma patients and in patients with acquired immunodeficiency syndrome (AIDS).
    Dröge W; Eck HP; Betzler M; Näher H
    Immunobiology; 1987 Aug; 174(4-5):473-9. PubMed ID: 3679279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect.
    Dröge W; Eck HP; Näher H; Pekar U; Daniel V
    Biol Chem Hoppe Seyler; 1988 Mar; 369(3):143-8. PubMed ID: 2897198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial recovery of lymphocyte activity in patients with colorectal carcinoma after curative surgical treatment and return of plasma glutamate concentrations to normal levels.
    Eck HP; Betzler M; Schlag P; Dröge W
    J Cancer Res Clin Oncol; 1990; 116(6):648-50. PubMed ID: 1979329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma melatonin levels in patients suffering from colorectal carcinoma.
    Khoory R; Stemme D
    J Pineal Res; 1988; 5(3):251-8. PubMed ID: 3404397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma glutamate concentration and lymphocyte activity.
    Dröge W; Eck HP; Betzler M; Schlag P; Drings P; Ebert W
    J Cancer Res Clin Oncol; 1988; 114(2):124-8. PubMed ID: 2895110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-dependent cellular cytotoxicity (ADCC) in colorectal carcinoma. II. Blood group association.
    Jones SL; Pihl E; Nind AP; Chalmers PJ; Nairn RC
    J Surg Oncol; 1983 Nov; 24(3):229-32. PubMed ID: 6355663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma glutamate concentrations in HIV-1-infected patients may contribute to loss of macrophage and lymphocyte functions.
    Eck HP; Frey H; Dröge W
    Int Immunol; 1989; 1(4):367-72. PubMed ID: 2577375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters.
    Wanebo HJ; Rao B; Attiyeh F; Pinsky C; Middleman P; Stearns M
    Cancer; 1980 Mar; 45(5 Suppl):1254-63. PubMed ID: 7357518
    [No Abstract]   [Full Text] [Related]  

  • 10. T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different aetiologies.
    Eck HP; Mertens T; Rosokat H; Fätkenheuer G; Pohl C; Schrappe M; Daniel V; Näher H; Petzoldt D; Drings P
    Int Immunol; 1992 Jan; 4(1):7-13. PubMed ID: 1347232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amino acid uptake and release by colorectal cancer in man].
    Striebel JP; Saeger HD; Ritz R; Leweling H; Holm E
    Infusionsther Klin Ernahr; 1986 Apr; 13(2):92-104. PubMed ID: 2872164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome.
    Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA
    J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
    McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
    Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of plasma CEA in patients with colorectal carcinoma.
    Koch M; McPherson TA
    J Surg Oncol; 1979 Dec; 12(4):319-25. PubMed ID: 522488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between serum alpha-globulin and plasma inhibitory effect on PHA-stimulated lymphocytes in colon cancer patients.
    Hsu CC; LoGerfo P
    Proc Soc Exp Biol Med; 1972 Feb; 139(2):575-8. PubMed ID: 4110342
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma glutamate--a prognostic marker of cancer and of other immunodeficiency syndromes?
    Ollenschläger G; Karner J; Karner-Hanusch J; Jansen S; Schindler J; Roth E
    Scand J Clin Lab Invest; 1989 Dec; 49(8):773-7. PubMed ID: 2575787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.
    Elias EG; Holyoke ED; Chu TM
    Dis Colon Rectum; 1974; 17(1):38-41. PubMed ID: 4204181
    [No Abstract]   [Full Text] [Related]  

  • 18. Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetyl-cysteine.
    Dröge W
    Pharmacology; 1993; 46(2):61-5. PubMed ID: 8441757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spontaneous course of LAV/HTLV-III infection. Follow-up of persons from AIDS-risk groups].
    Brodt HR; Helm EB; Werner A; Joetten A; Bergmann L; Klüver A; Stille W
    Dtsch Med Wochenschr; 1986 Aug; 111(31-32):1175-80. PubMed ID: 3015546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.
    Eck HP; Drings P; Dröge W
    J Cancer Res Clin Oncol; 1989; 115(6):571-4. PubMed ID: 2558118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.